Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 26 September 2025
First Online: 31 October 2025
Competing interests
: D.K.N. is a co-founder, shareholder and scientific advisory board member for Frontier Medicines and Zenith Therapeutics, is also on the scientific advisory board of and receives payment and/or holds shares in The Mark Foundation for Cancer Research, Oerth Bio, Photys Therapeutics, Apertor Pharmaceuticals, Oerth Bio, Ten30 Biosciences, and Deciphera Pharmaceuticals, and is an Investment Advisory Partner for a16z Bio, an Advisory Board member for Droia Ventures, and an iPartner for The Column Group.
